First, the patient presented with diabetes (most likely due to the predominance of the glucagonoma) and later developed hyperinsulinemic hypoglycemia, which is probably the consequence of the GLP-1 excess, which acts as a potent insulin secretagogue. The gene discussed is GLP1R; the disease is hyperinsulinemic hypoglycemia.